All Articles

CTMS cloud application streamlines trial management and delivers end-to-end visibility of clinical trials on one platform
ZERVIATE was established in three randomized, double-masked, placebo-controlled, conjunctival antigen challenge (Ora-CAC®3 model of allergic conjunctivitis)
Digging deeper into the types of patients who get dry eye and the situations that can bring it on.
Ophthalmic Product Development Insights
Visit Ora at booths #4406 and #4206 or set up a meeting with us to learn how we can help guide your product development.
Results of the first phase 3 trial in this field were announced.
Okogen, Inc. to present at 2017 Biotech Showcase

Pages